AzTrials
AzTrials

CholedocholithiasisNCT00612846

Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk Patients

A study testing Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy and Laparoscopic bile duct exploration during cholecystectomy in people with Choledocholithiasis and Higher Risk Patients, run by North Bristol NHS Trust.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The aim of the trial is to compare two operations which are used to treat bile duct stones. The hypothesis of the study is that there is no difference between endoscopic sphincterotomy followed by laparoscopic cholecystectomy or laparoscopic bile duct exploration during laparoscopic cholecystectomy in the treatment of… Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Choledocholithiasis, Higher Risk Patients
What is being tested?
Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy and Laparoscopic bile duct exploration during cholecystectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
91 participants
Where
No sites listed yet
Study dates
Mar 2000to Mar 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Gallbladder stones
  • At least strong evidence of bile duct stones (abnormal LFTs and dilated bile duct)
  • Higher risk (>70yrs, >60yrs with co-morbidity, >50 with BMI>40)

Who cannot join

  • Not fit for general anaesthesia
  • Cholangitis requiring emergency ERCP
  • Previous upper GI surgery making ERCP impossible

About this study

Official title: A Randomised Clinical Trial to Compare Endoscopic Sphincterotomy and Subsequent Laparoscopic Cholecystectomy With Primary Laparoscopic Bile Duct Exploration During Cholecystectomy in Higher Risk Patients With Choledocholithiasis

The aim of the trial is to compare two operations which are used to treat bile duct stones. The hypothesis of the study is that there is no difference between endoscopic sphincterotomy followed by laparoscopic cholecystectomy or laparoscopic bile duct exploration during laparoscopic cholecystectomy in the treatment of bile duct stones in higher risk patients.

Being tested
Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy, Laparoscopic bile duct exploration during cholecystectomy
Keywords
Common Bile Duct Calculi, Choledocholithiasis, Endoscopic sphincterotomy, Cholecystectomy, laparoscopic, Laparoscopic bile duct exploration
Medical subject headings
Choledocholithiasis, Gallstones

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomyProcedure or surgery

    Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy

  • Laparoscopic bile duct exploration during cholecystectomyProcedure or surgery

    Laparoscopic bile duct exploration during cholecystectomy

Study groups in NCT00612846
Study groupRoleWhat they receive
AExperimentalNot described
Receives: Procedure: Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy
BExperimentalNot described
Receives: Procedure: Laparoscopic bile duct exploration during cholecystectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bile duct clearance

    Measured: Peri-operative

Secondary outcomes (4)
  1. Morbidity and mortality

    Measured: 30 day or directly relating to intervention

  2. Post-operative stay

    Measured: Post-operative stay

  3. Procedures per patient

    Measured: Interventions required to acheive duct clearance

  4. Conversion to open surgery

    Measured: Peri-operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2008 (estimated)
  2. Study startMar 2000
  3. Primary completionMar 2006
  4. Study completionMar 2006

Why it stopped: Terminated early due to slow recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
91 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00612846
Sponsor's protocol ID
112/99
Status last verified
Jan 2008
First submitted
29 Jan 2008
Last updated
12 Feb 2008
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy and Laparoscopic bile duct exploration during cholecystectomy in people with Choledocholithiasis and Higher Risk Patients, run by North Bristol NHS Trust.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 12 Feb 2008. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Terminated early due to slow recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bile duct clearance (time frame: Peri-operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in